In vitro studies of cytokine toxicity using genetically modified beta-cells, naturally occurring SLs and their analogues suggest that alterations of beta-cell SLs may affect insulin secretory capacity and beta-cell fate during T1DM development. Here, INS is linked to type 1 diabetes mellitus.